About Us

Dr. Kunakorn C. Atchaneeyasakul, serves as the CEO of Gravity Medical Technology, where he leads the company’s mission to develop efficient and accessible stroke care solutions. He also serves on the core committee of the Society of Vascular and Interventional Neurology's Mission Thrombectomy initiative, advocating for equitable global access to mechanical thrombectomy for stroke patients. As a Vascular and Interventional Neurologist at Virginia Mason Medical Center, Dr. Atchaneeyasakul brings extensive expertise in both clinical practice and public health.

With a background that includes a Master’s in Public Health from Johns Hopkins University and prior academic roles such as Assistant Professor of Neurology at the University of Pittsburgh, he has led research efforts focusing on large animal models and device development. His leadership in stroke treatment research extends to international collaborations aimed at improving stroke outcomes in underserved regions such as Southeast Asia​.

Dr. Shashvat Desai is a pioneering physician-scientist specializing in vascular neurology and endovascular neurosurgery. As the co-founder and Chief Technology Officer of Gravity Medical Technology, he has been at the forefront of developing innovative and value-based neurointerventional devices, designed to enhance the treatment of stroke and reduce healthcare disparities across the world.

Dr. Desai completed his medical education at Seth GS Medical College and KEM Hospital in Mumbai, followed by specialized training at the University of Pittsburgh and Barrow Neurological Institute. His extensive research contributions, including over 100 peer-reviewed publications, have been widely recognized within the global neurology community. He has also served as a fellow of the National Institutes of Health (NIH), where his work focuses on creating efficient, accessible solutions for stroke treatment. As Medical Director of the Neurovascular Device Lab at HonorHealth in Arizona, Dr. Desai leads efforts in the development of novel devices that improve procedural outcomes, emphasizing his commitment to transforming stroke care.

Dr. Jadhav, is a globally renowned expert in vascular and interventional neurology. He currently serves as the Chief Scientific Officer at Gravity Medical Technology and is the Director of Vascular and Interventional Neurology at HonorHealth/Barrow Neurological Institute in Arizona. Dr. Jadhav's academic background includes an MD from Harvard Medical School and a PhD in Biochemical Sciences. He completed his residency at Massachusetts General Hospital/Brigham and Women’s Hospital and fellowships in vascular neurology and interventional neurology at the University of Pittsburgh Medical Center.

Dr. Jadhav has contributed significantly to several pivotal clinical trials, including DAWN, STRATIS, and SWIFT PRIME, which have shaped modern stroke care. He is also the Editor-in-Chief of Stroke: Vascular and Interventional Neurology, further cementing his role as a leader in the field. His extensive involvement in cutting-edge neurointervention research and clinical innovation continues to influence stroke treatment protocols globally​.

Dr. Adrian M. Burgos specializes in Vascular Neurology and is currently the Director of the Comprehensive Stroke Center at PIH Health System in Los Angeles. With extensive expertise in stroke care across multihospital systems, Dr. Burgos has been instrumental in advancing stroke treatment protocols and improving outcomes for patients in complex healthcare settings. His leadership at PIH Health System has transformed stroke care delivery, integrating cutting-edge technology and innovative approaches to optimize patient recovery.

As Global Strategic Advisor to Gravity Medical Technology, Dr. Burgos brings his deep clinical expertise and strategic insights to enhance the company's mission of revolutionizing medical technology for stroke care. His work in building a comprehensive stroke system of care makes him an invaluable partner in shaping the future of stroke management on a global scale.

Dr. Dileep R. Yavagal is a prominent figure in stroke care and endovascular therapies. He serves as Director of Interventional Neurology and Co-Director of Neuroendovascular Surgery at the University of Miami, where he also leads the NeuroStem Cell Division. Dr. Yavagal has been instrumental in pioneering research on intra-arterial delivery of stem cells for stroke therapy, leading multiple clinical trials including the groundbreaking DAWN trial. His contributions to stroke care extend globally through his role in founding the Society of Vascular and Interventional Neurology (SVIN) and leading the Mission Thrombectomy 2020+ initiative, which aims to expand access to life-saving mechanical thrombectomy treatments worldwide.

In addition to these roles, Dr. Yavagal serves as Global Principal Investigator for the GRASSROOT trial, a key study focused on advancing stroke care. He continues to shape the field through his research, clinical leadership, and advocacy for increased stroke treatment access globally.

Dr. Tudor G. Jovin is a world leader in vascular and interventional neurology, currently serving as Chairman of the Cooper Neurological Institute. As a senior steering committee member of the GRASSROOT Trial, a groundbreaking project at Gravity, Dr. Jovin plays a critical role in advancing research and innovation in endovascular stroke therapy. His expertise spans clinical trials in stroke intervention, where he has consistently pushed the boundaries of stroke care.

In 2022, Dr. Jovin was recognized as the Highest Cited Neurointerventional Researcher, a testament to his profound impact on the field. His work has influenced modern approaches to stroke treatment, helping shape protocols that save lives and improve outcomes for stroke patients worldwide. Dr. Jovin’s collaboration with Gravity Medical Technology aligns with his mission to integrate cutting-edge research with clinical practice, ensuring that the future of stroke care is both innovative and effective.

Prof. David S. Liebeskind is a world-renowned leader in stroke imaging and intracranial atherosclerosis research. As Director of both the UCLA Stroke Center and the Neurovascular Imaging Research Core, he has spearheaded transformative studies that have advanced stroke diagnostics and treatment strategies globally. His groundbreaking contributions to neurovascular imaging have not only set new standards in clinical care but have also paved the way for future innovations in stroke management.

Recognized as the Highest Cited Stroke Researcher in 2022, Prof. Liebeskind’s influential work continues to shape modern stroke care. As a valued member of Gravity Medical Technology’s Board of Advisors and Chair of the Imaging Core Lab for the GRASSROOT trial, his expertise is crucial in guiding the development of cutting-edge technologies that aim to revolutionize stroke treatment and improve patient outcomes worldwide.

Dr. Kaiz Asif is a Consultant in Neuroendovascular Surgery and Stroke, with a deep commitment to improving systems of care for rapid hyperacute stroke treatment. He has been instrumental in strengthening a telestroke network, optimizing the hub-and-spoke transfer process, and leading comprehensive stroke certification efforts at Resurrection Medical Center, Chicago, and St. Joseph Medical Center, Joliet.

As the Chair of the Regional Stroke Subadvisory Committee for Illinois Region VII, Dr. Asif is a key leader in developing EMS triage pathways to enhance regional stroke response. He is also passionate about individualized risk factor modification and stroke prevention, actively working on evidence-based, tech-enabled, and data-driven programs aimed at community education and awareness.

In his research capacity, Dr. Asif has served as a local principal investigator for multiple national and international randomized controlled trials and initiated several local studies. His involvement extends to training neurosurgery residents and fellows, contributing to the next generation of neuroendovascular specialists.

Prof. Naoki Kaneko is a pioneering endovascular neurosurgeon and a leader in the development of innovative treatments for neurovascular diseases. He spearheads pre-clinical research for advanced endovascular devices and had been instrumental in successful commercialization of every major neurointerventional device in the United States.

Prof. Kaneko holds an MD and PhD from Tohoku University in Japan and completed his neurosurgery residency at Jichi Medical University. His early research focused on computational fluid dynamics (CFD) and rodent aneurysm models, and he later deepened his expertise while studying neuronal death at Albert Einstein College of Medicine. After joining UCLA’s division of neurointerventional radiology in 2016, Prof. Kaneko became a faculty member in 2018.

Throughout his career, he has worked on integrating open microsurgery, minimally invasive endovascular surgery, and 3D printing technologies. His research, supported by prestigious NIH-R01 grants and funding from the Brain Aneurysm Foundation, aims to develop robotic systems that increase the precision and accessibility of aneurysm treatments globally.

Asst. Prof. Jaydevsinh Dolia, MD is a Vascular and Interventional Neurologist at Emory University and a dedicated member of Gravity mission. With a deep commitment to education, Dr. Dolia plays a pivotal role on the Media and Education Committee of the Society of Vascular Interventional Neurology (SVIN), where he helps develop compreheve nsi training programs and educational content for stroke specialists worldwide. His leadership in neurointervention education is instrumental in shaping the future of stroke care.

In his role within the GRASSROOT trial, Dr. Dolia leads cutting-edge research aimed at improving stroke treatment outcomes, particularly in underserved regions. He is passionate about advancing neurointerventional technologies while ensuring that medical education evolves alongside the field’s rapid developments. Dr. Dolia’s contributions to clinical practice, education, and international research have solidified his reputation as a forward-thinking leader in vascular neurology.

Dr. Satoshi Tateshima is a Professor of Radiology and Neurosurgery at UCLA and a senior clinical faculty member of the Interventional Neuroradiology division at the Ronald Reagan UCLA Medical Center. With an extensive background in endovascular neurosurgery and interventional neuroradiology, Dr. Tateshima specializes in treating complex cerebrovascular conditions such as intracranial aneurysms, AVMs, and ischemic stroke.

Dr. Tateshima is known for pioneering the world’s first fully robotic embolization procedure, a breakthrough that opens the door for remote neurointerventional treatments. His research, supported by NIH and industry grants, focuses on robotic interventions, novel device development, and material surface modification for neurovascular devices. Dr. Tateshima holds several patents in endovascular technologies and continues to lead innovative research in neurovascular care​.

Dr. Shahid Nimjee is a renowned neurological surgeon and associate professor at The Ohio State University Wexner Medical Center. He serves as the co-director of the Comprehensive Stroke Center, specializing in both open and endovascular neurosurgery. His research focuses on developing RNA-based therapies to treat thromboembolic diseases, including strokes, aiming to revolutionize stroke treatment by targeting clot formation at the molecular level.

Dr. Nimjee completed his MD and PhD at Duke University, followed by a residency and fellowship in cerebrovascular neurosurgery. His groundbreaking research has earned him a reputation as a leader in stroke therapy innovations, with ongoing clinical trials focused on translating his discoveries into life-saving treatments for stroke patients.

Dr. Sirintara Pongpech is a pioneer in Neurointerventional Radiology in Thailand and currently serves as the Consultant Chief of the Neurointervention Unit at Ramathibodi Hospital, Mahidol University. She is also the Deputy Dean for International Relations and Research Collaborations at the Faculty of Medicine, Mahidol University. A trailblazer in her field, Dr. Pongpech has made substantial contributions to neurovascular care, both in Thailand and globally, particularly through her leadership as the President of the World Federation of Interventional and Therapeutic Neuroradiology (WFITN) from 2015 to 2017.

Dr. Pongpech completed her medical education at Mahidol University and pursued specialized training in Interventional Neuroradiology in France. Her work focuses on advancing stroke intervention and neurovascular treatments, and she has been instrumental in organizing the PLANET International Neurovascular Course. With numerous awards recognizing her international impact, Dr. Pongpech remains a key figure in improving neurointerventional practices and education across South-East Asia.

Yuvateja Thotamalla is the Global Executive Manager at Gravity Medical Technology, where he leads the global strategy and development of next-generation stroke care technologies. Specializing in medical devices, global operations, clinical trials, registries, regulatory affairs, and market expansion, he drives initiatives that bridge advanced medical technology with underserved populations.

Before joining Gravity, Yuvateja served as a Management and Strategy Consultant and as a Program Manager at SVIN Mission Thrombectomy. Collaborating with key opinion leaders across the U.S., Europe, China, and the JAPAC regions, he provided strategic insights on market opportunities, disease states, patient pathways, and emerging technologies. He conducted due diligence for strategic partnerships and managed programs that expanded access to mechanical thrombectomy through provider training and public awareness initiatives in over 100 countries.

Yuvateja completed his education in Electrical Engineering and Entrepreneurship and Management at the Indian Institute of Technology, Hyderabad (IITH). His passion for building healthcare systems is driven by a commitment to improving accessibility and equity in global health systems.

Akhil Gadam is the Executive Manager for India at Gravity Medical Technology, where he focuses on making Gravity’s advanced stroke technology accessible across India and parts of Southeast Asia. With extensive experience in strategic consulting and program management, Akhil is committed to addressing healthcare disparities by bringing life-saving innovations to underserved regions.

Prior to joining Gravity, Akhil previously worked as a Strategic Consultant and Program Manager at Society of Vascular and Interventional Neurology’s Mission Thrombectomy. During these roles, he gained valuable insight into global healthcare challenges specifically in stroke care and collaborated with leading medical professionals to implement effective solutions.

Akhil holds an MBA in Marketing from Osmania University, Hyderabad. He combines his marketing expertise with a passion for healthcare innovation, driving Gravity Medical Technology’s mission to improve stroke care access in key regions.

Dr. Bindiya Pahuja is the Clinical Research Coordinator for the GRASSROOT clinical trial in India at Gravity Medical Technology. With her background in periodontology and implantology, and extensive experience in clinical and translational research, Dr. Pahuja plays a critical role in overseeing the trial's implementation in India. She has previously held research and clinical positions at AIIMS New Delhi, contributing to various healthcare initiatives.

Dr. Pahuja's work focuses on ensuring that the GRASSROOT clinical trial effectively addresses stroke care challenges in India, with an emphasis on leveraging research to develop innovative, accessible treatment solutions. Her leadership in managing the clinical trial operations in India are pivotal in advancing Gravity mission of improving stroke care in underserved regions of India.

As the Executive Manager at Gravity Medical Technology (Thailand) Co., Ltd., Santaya Chaihan leads strategic initiatives and serves as the key liaison for the company’s operations in Thailand. She is responsible for building strong partnerships and nurturing key stakeholder relationships while ensuring seamless cross-functional collaboration to drive operational excellence. With a Bachelor of Arts from Silpakorn University, Santaya combines her educational background with her expertise in business development and market expansion to advance Gravity's mission of delivering innovative medical technologies that enhance patient care. Her deep passion for healthcare innovation is reflected in her commitment to improving accessibility and efficiency within the healthcare system.

Industry: Medical Devices

Erik grew up in Maryland and moved to California to focus on a career in the medical device industry. With over 10+ years of experience, he has worked in the Quality and Regulatory functions for Fortune 500 and startup companies. He began his career as a quality engineer where he developed expertise in change management, process optimization, and regulatory compliance.​

Erik has since been a key player in the development and approval of several neurovascular, neuroimaging, and cardiovascular devices. His decision-making skills, leadership, and attention to detail lead to quality products in design and manufacturing. Recently, he decided to create his own business to help small and mid-size healthcare companies grow sustainably and bring their products to the market. ​

While at Anderson, Erik held a leadership position in the Healthcare Business Association and provides tutoring services to students in various MBA courses. Outside of the classroom, Erik loves playing basketball, hiking, and drawing. ​

He received his Bachelor Degree in Biomedical Engineering from Georgia Institute of Technology, Atlanta, GA in 2012.